A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease
NCT00081497
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class
Conditions
Fabry Disease
Interventions
BIOLOGICAL:
agalsidase beta
Sponsor
Genzyme, a Sanofi Company